摘要
The invention relates to methods and biomarker for evaluating cancer metastasis, pharmaceutical composition for inhibiting cancer metastasis,
and method for analyzing secretome. By combining a hollow fiber cartridge (HFC) culture system with quantitative proteomics technology,
cancer metastasis-related secrectomes can be found. Furthermore, this is the first time to use PARK7 as a biomarker for judging the process of non-small cell lung cancer.
| 貢獻的翻譯標題 | 癌症轉移之評估方法及生物標記、抑制癌症轉移之醫藥組成物、及分泌蛋白質體之分析方法 |
|---|---|
| 原文 | English |
| 專利號 | 9194005 |
| 出版狀態 | Published - 1800 |
UN SDG
此研究成果有助於以下永續發展目標
